Africa cannot buy its way to health. It must govern its way there

For decades, international donors and African governments have financed targeted health programmes (HIV, malaria, vaccination) without durably reducing health inequities. This is the recurring debate into which this partner content, published by African Business on 23 July 2026, fits. The text, very short, puts forward a central thesis: 'Health equity is not a health-sector problem.' It states that until budgets, infrastructure and industrial policy are organised around the same people and places, 'disease-specific gains will keep resting on systems that manufacture vulnerability.' No figures, studies or named experts accompany this claim in the available text. If this reading holds, it implies that vertical health campaigns would remain fragile without convergence between African states' budgetary, industrial and territorial choices, raising questions about inter-ministerial coordination and donors' disease-specific funding model. This thesis echoes the broader debate on the 'social determinants of health' championed by institutions such as the WHO. However, lacking quantitative data, country examples or an identified author, this text reads more as an analytical advocacy piece than a verifiable factual investigation.